| Advancing Care in MASLD Programme | Time (SGT) |
|---|---|
| Welcome Address | |
| Theme 1: Integration Chair: Dr. Mark Muthiah & Dr. Daniel Huang |
|
| Global format for care pathways in metabolic medicine – how is the world moving towards integration Prof. Arun Sanyal View Bio |
|
| A pathobiological view of common biological roots of metabolic end organ damage Prof. Quentin Antsee View Bio |
|
| Case based discussions: extrahepatic involvement in MASLD Dr. Nicholas Chew View Bio |
|
| Combined Q&A | |
| Tea Break | |
| Theme 2: Diagnostics Chair: Prof. Atsushi Nakajima and Prof. Ming Hua Zheng |
|
| Unmet needs in diagnostics: a patient centered view Prof. Chan Wah Kheong View Bio |
|
| From diagnostics to surrogate endpoints: current state of the art Prof. Quentin Anstee View Bio |
|
| Innovations in diagnostics Prof. Arun Sanyal View Bio |
|
| Case based discussions: challenges in diagnostics Prof. Atsushi Nakajima View Bio and Dr. Mark Muthiah View Bio |
|
| Combined Q&A | |
| d. Q&A | |
| Theme 3: Treatment Chair: Dr. Daniel Huang & Dr. Mark Muthiah |
|
| Top-down vs bottom up strategies in MASLD therapeutics? Prof. Arun Sanyal View Bio |
|
| When and how of combination therapies Prof. Zheng Ming Hua View Bio |
|
| Case based discussion: management challenges Dr. Mark Muthiah View Bio Prof. Dan Yock Young View Bio |
|
| Tea Break | |
| Theme 4: Hot topics Chair: Dr. Yew Kuo Chao & Prof. Chan Wah Kheong |
|
| Non hepatic cancer in MASLD Prof. Asahiro Morishita View Bio |
|
| Implications of MASLD for women of childbearing years Dr. Mark Muthiah View Bio |
|
| Neurocognitive decline in MASLD Prof. Ajay Duseja View Bio |
|
| HCC and the core total in MASLD Dr. Daniel Huang View Bio |
|
| Combined Q&A | |
| Closing address |
